Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals

Science Translational Medicine
Volume 14| Issue 631| 9 Feb 2022
https://www.science.org/toc/stm/current

 

Research Articles
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals
BY Marie I. Samanovic, et al.
09 Feb 2022
Open Access
Prior history of COVID-19 enhances adaptive immune responses to mRNA vaccination.